The global regenerative medicine market is poised for remarkable expansion, expected to record a compound annual growth rate (CAGR) of around 17% during the forecast period. This surge is primarily ...
This article was reviewed by Knox Beasley, MD. Exosomes for Hair Loss: Costs, Safety, Efficacy, & Benefits The deeper you ...
As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus ...
The same cell product could potentially be used to treat multiple solid tumors like ovarian, pancreatic and lung cancers.
New Florida stem cell law provides ZEO with new pathways to market and sell regenerative therapy products and advance ...
GV- and Arch-backed Pelage Pharma is developing a first-of-its-kind topical stem-cell therapy that could redefine the $10B ...
In a discovery that ties the biology of aging to cancer risk, scientists from the University of Tokyo have found that the ...
In the U.S., the generic name for Libtayo in its approved indications is cemiplimab-rwlc, with rwlc as the suffix designated in accordance with Nonproprietary Naming of Biological Products Guidance ...
Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host diseaseParis, October 17, 2025. The European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback